Association of botulinum neurotoxin serotypes A and B with synaptic vesicle protein complexes

被引:48
作者
Baldwin, Michael R. [1 ]
Barbieri, Joseph T. [1 ]
机构
[1] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA
关键词
D O I
10.1021/bi602396x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Botulinum neurotoxins (BoNTs) elicit flaccid paralysis through cleavage of SNARE proteins within peripheral neurons. There are seven serotypes of the BoNTs, termed A-G, which differ in the SNARE protein and/or site that is cleaved. BoNTs are single-chain toxins that comprise an N-terminal zinc metalloprotease domain that is disulfide linked to the C-terminal translocation/receptor binding domain. SV2 and synaptotagmin have been identified as receptors for BoNT serotypes A and B, respectively. Using affinity chromatography, BoNTs A and B were observed to bind synaptic vesicle protein complexes in synaptosome lysates. Tandem LC-MS/MS identified SV2, synaptotagmin I, synaptophysin, vesicle-associated membrane protein 2 (VAMP2), and the vacuolar proton pump as components of the BoNT-receptor complex. Density gradient analysis showed that BoNT serotypes A and B exhibited unique interactions with the synaptic vesicle protein complexes. The association of BoNT serotypes A and B with synaptic vesicle protein complexes implicates a physiological role for protein complexes in synaptic vesicle biology and provides insight into the interactions of BoNT and neuronal receptors.
引用
收藏
页码:3200 / 3210
页数:11
相关论文
共 52 条
[1]   Anthrax toxin triggers endocytosis of its receptor via a lipid raft-mediated clathrin-dependent process [J].
Abrami, L ;
Liu, SH ;
Cosson, P ;
Leppla, SH ;
van der Goot, FG .
JOURNAL OF CELL BIOLOGY, 2003, 160 (03) :321-328
[2]   Characterization of the antibody response to the receptor binding domain of botulinum neurotoxin serotypes A and E [J].
Baldwin, MR ;
Tepp, WH ;
Pier, CL ;
Bradshaw, M ;
Ho, MF ;
Wilson, BA ;
Fritz, RB ;
Johnson, EA ;
Barbieri, JT .
INFECTION AND IMMUNITY, 2005, 73 (10) :6998-7005
[3]   The C-terminus of botulinum neurotoxin type A light chain contributes to solubility, catalysis, and stability [J].
Baldwin, MR ;
Bradshaw, M ;
Johnson, EA ;
Barbieri, JT .
PROTEIN EXPRESSION AND PURIFICATION, 2004, 37 (01) :187-195
[4]   Characterization of synaptogyrin 3 as a new synaptic vesiclie protein [J].
Belizaire, R ;
Komanduri, C ;
Wooten, K ;
Chen, M ;
Thaller, C ;
Janz, R .
JOURNAL OF COMPARATIVE NEUROLOGY, 2004, 470 (03) :266-281
[5]   SYNAPTIC VESICLE MEMBRANE-PROTEINS INTERACT TO FORM A MULTIMERIC COMPLEX [J].
BENNETT, MK ;
CALAKOS, N ;
KREINER, T ;
SCHELLER, RH .
JOURNAL OF CELL BIOLOGY, 1992, 116 (03) :761-775
[6]   BOTULINUM NEUROTOXIN-A SELECTIVELY CLEAVES THE SYNAPTIC PROTEIN SNAP-25 [J].
BLASI, J ;
CHAPMAN, ER ;
LINK, E ;
BINZ, T ;
YAMASAKI, S ;
DECAMILLI, P ;
SUDHOF, TC ;
NIEMANN, H ;
JAHN, R .
NATURE, 1993, 365 (6442) :160-163
[7]  
BLASI J, 1993, EMBO J, V12, P4821, DOI 10.1002/j.1460-2075.1993.tb06171.x
[8]   Identification of the cellular receptor for anthrax toxin [J].
Bradley, KA ;
Mogridge, J ;
Mourez, M ;
Collier, RJ ;
Young, JAT .
NATURE, 2001, 414 (6860) :225-229
[9]   Roles of complex gangliosides at the neuromuscular junction [J].
Bullen, RWM ;
O'Hanlon, GM ;
Wagner, E ;
Molenaar, PC ;
Furukawa, K ;
Furukawa, K ;
Plomp, JJ ;
Willison, HJ .
MYASTHENIA GRAVIS AND RELATED DISORDERS: BIOMCHEMICAL BASIS FOR DISEASE OF THE NEUROMUSCULAR JUNCTION, 2003, 998 :401-403
[10]  
Bullens RWM, 2002, J NEUROSCI, V22, P6876